Timely Diabetes Care Demands a New Approach to Testing

Half of all adults currently living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes.

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home. 

Simplified testing.  Increased patient throughput.  Better outcomes. 

Timely Diabetes Care Demands a New Approach to Testing

Half of all adults currently living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes.

Digostics' revolutionary new testing platforms offer the world's first and only alternative to in-clinic testing for glucose intolerance by enabling the oral glucose tolerance test (OGTT) to be performed at home. 

Simplified testing.  Increased patient throughput.  Better outcomes. 

100% Focus on Diabetes

Digostics create and deliver class-leading test and service platforms that enable the early identification of diabetes through efficient screening of at-risk individuals.

With the support of leading clinical advisors and academic partners, we are proud to offer groundbreaking solutions that push the boundaries of what is achievable in diabetes detection.

Leaders in Remote Diabetes Testing

Digostics uses advanced wireless and sensor technologies to enable safe and secure diabetes testing at home.

We ensure that a greater number of patients can be screened for diabetes without compromising test accuracy or adding to the burden of overworked clinical care teams.

GTT@home is Digostics' breakthrough solution and the world's first and only home OGTT, conveniently providing clinic-equivalent test results.

Leaders in Remote Diabetes Testing

Digostics uses advanced wireless and sensor technologies to enable safe and secure diabetes testing at home.

We ensure that a greater number of patients can be screened for diabetes without compromising test accuracy or adding to the burden of overworked clinical care teams.

GTT@home is Digostics' breakthrough solution and the world's first and only home OGTT, conveniently providing clinic-equivalent test results.

Patient-Centric Design and Human Factors

Unlocking the full population health potential of diabetes screening at home requires the elimination of all procedural complexities, allowing patients to complete their tests confidently without the need for clinical assistance.

With our deep expertise in human factors and by thorough extensive user testing and refinement, Digostics ensures that our diabetes home testing solutions are as convenient and effortless to use as they are accurate.
 

Patient-Centric Design and Human Factors

Unlocking the full population health potential of diabetes screening at home requires the elimination of all procedural complexities, allowing patients to complete their tests confidently without the need for clinical assistance.

With our deep expertise in human factors and by thorough extensive user testing and refinement, Digostics ensures that our diabetes home testing solutions are as convenient and effortless to use as they are accurate.
 

Empowering Clinical Research

Digostics' cutting-edge diagnostic platforms allow clinical researchers to access at speed and scale tests that were previously a major barrier to achieving breakthroughs.  

We are adding new test and service elements to our platforms to empower researchers by easing patient recruitment, boosting compliance, reducing clinic visits and enriching datasets.

Open Architecture and System Interoperability

Digostics is a strong advocate of interoperability.  That's why all our diabetes testing platforms are built with an open architecture and adhere to the HL7 FHIR standards.

Clinical users have the freedom to perform a range of tasks, from scheduling tests to analysing data, securely and conveniently within our software.  Alternatively, they can draw on our API and productised integrations to undertake the same activity from within their preferred adjacent hospital systems.

Empowering Clinical Research

Digostics' cutting-edge diagnostic platforms allow clinical researchers to access at speed and scale tests that were previously a major barrier to achieving breakthroughs.  

We are adding new test and service elements to our platforms to empower researchers by easing patient recruitment, boosting compliance, reducing clinic visits and enriching datasets.